IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q3 2019 Holdings

Filed 2019-11-15 | 10 holdings | $43.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$41.1M176,71094.4%
Avanos Medical Inc(AVNS)COM05350V106$2.2M59,4295.1%
United Therapeutics Corp(UTHR)COM91307C102$43.1K540,0940.1%
McKesson Corp(MCK)COM58155Q103$40.1K293,2970.1%
Gilead Sciences Inc(GILD)COM375558103$35.0K551,7150.1%
Enanta Pharmceuticals Inc(ENTA)COM29251M106$30.0K498,8740.1%
Alexion Pharmaceuticals Inc(ALXN)COM015351109$25.0K255,0000.1%
Elanco Animal Health Inc(ELAN)COM28414H103$23.7K892,6200.1%
RTI Surgical HDS IncCOM74975N105$11.1K3,890,3240.0%
Invacare CorpCOM461203101$9.2K1,224,7610.0%